MethazolAMIDE 25 mg Oral Tablet
RxNorm 197939
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 197939 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: methazolAMIDE 25 mg Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
Methazolamide 25 mg Oral Tablet
(Atom ID: 12324525)
PSNPrescribable
Prescribable Name (PSN):
MethazolAMIDE 25 mg Oral Tablet
(Atom ID: 12438081)
TMSYPrescribable
Tall Man Lettering Synonym (TMSY):
MethazolAMIDE 25 mg Oral Tablet
(Atom ID: 12428328)
PTPrescribable
Designated preferred name (PT):
Methazolamide 25 mg oral tablet
(Atom ID: 9251832)
FNPrescribable
Full form of descriptor (FN):
Product containing precisely methazolamide 25 mg/1 each conventional release oral tablet (clinical drug)
(Atom ID: 10314699)
Patient Education
Methazolamide
Methazolamide is used to treat glaucoma (a condition in which increased pressure in the eye can lead to gradual loss of vision). Methazolamide is in a class of medications called carbonic anhydrase inhibitors. It works by decreasing the pressure in the eye.
[Learn More]
* Please review the disclaimer below.